Previously, we have shown that HKPS was also more cytotoxic to B-ALL cells than the strong and more unspecific PKC inhibitor, Staurosporine [16], showing even more its eventual therapeutic effectiveness. The gene discussed is PRRT2; the disease is acute lymphoblastic leukemia.